These findings highlight potential therapeutic opportunities, such as targeting TGF-β-mediated fibrosis or refining anti-arrhythmic strategies through ion channel modulation17, paving the way for potential interventions in AF prevention and treatment. Here, TGFB1 is linked to atrial fibrillation.